SCHEMBL3973774

SCHEMBL3973774

CCNC(=S)Nc1cccc(OCCCCCc2ccccc2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.55
LMNA P02545 8/20 0.53
MAPT P10636 8/20 0.53
ALDH1A1 P00352 7/20 0.53
KMT2A Q03164 5/20 0.53
HTT P42858 3/20 0.53
MEN1 O00255 3/20 0.53
GAA P10253 4/20 0.52
NR1H4 Q96RI1 1/20 0.49
SMN1; SMN2 Q16637 4/20 0.48
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
ALOX12 P18054 2/20 0.46
MTNR1A P48039 1/20 0.46
MTNR1B P49286 1/20 0.46
TP53 P04637 1/20 0.46
MAOA P21397 1/20 0.46
MAOB P27338 1/20 0.46
SIRT2 Q8IXJ6 1/20 0.46
ALPL P05186 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3978647 0.91 MAPT (0.56) POLBLMNAMAPTALDH1A1KMT2A
SCHEMBL3973713 0.90 MAPT (0.58) POLBLMNAMAPTALDH1A1KMT2A
SCHEMBL3977435 0.89 KMT2A (0.65) POLBLMNAMAPTALDH1A1KMT2A
SCHEMBL3978454 0.89 KMT2A (0.63) POLBLMNAMAPTALDH1A1KMT2A
SCHEMBL3979628 0.89 RAB9A (0.60) POLBLMNAMAPTALDH1A1KMT2A
SCHEMBL3974861 0.89 MAPT (0.60) POLBLMNAMAPTALDH1A1KMT2A
SCHEMBL3979417 0.89 MAPT (0.60) POLBLMNAMAPTALDH1A1KMT2A
SCHEMBL3978324 0.89 MAPT (0.60) POLBLMNAMAPTALDH1A1KMT2A
SCHEMBL4278907 0.89 MAPT (0.60) POLBLMNAMAPTALDH1A1KMT2A
SCHEMBL3978198 0.88 ALDH1A1 (0.51) POLBLMNAMAPTALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101522184-A Thiourea compounds NAT HEALTH RESEARCH INSTITUTES (CN) 2009-09-02 CN disclosed
EP-2056810-A2 THIOUREA COMPOUNDS National Health Research Institutes (TW) 2009-05-13 EP disclosed
US-20080113975-A1 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-05-15 US disclosed
US-20080113975-A1 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-05-15 US disclosed
US-20080113975-A1 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-05-15 US disclosed
US-20080096875-A1 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-04-24 US disclosed
US-20080096875-A1 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-04-24 US disclosed
US-20080096875-A1 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-04-24 US disclosed
WO-2008022204-A2 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-02-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096875-A1 THIOUREA COMPOUNDS TPMT, HAVCR2, ETV6 POLB 3499/4885LMNA 4873/4885MAPT 3656/4885
US-20080113975-A1 THIOUREA COMPOUNDS TPMT, HAVCR2, EIF2AK2 POLB 3373/4885LMNA 4858/4885MAPT 3833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.